In her opinion, one of the primary reasons health authorities took this decision was to address the problem: the relationship between HPV infection and cervical cancer, she reflected on social media.

It is common for almost all sexually active people to become infected with some type of HPV in their lifetime. If an infection with these viruses persists for many years, it can cause slow changes in a woman’s cervical cells, which can eventually develop into cancer, she explained.

Cervical cancer is one of the leading causes of cancer-related death in women in many parts of the world, she warned.

The other is the solution: the HPV vaccine, a kind of “training” for your immune system.

It teaches your body to recognize and fight the most dangerous types of the virus before you’re exposed to them, the deputy director of the Finlay Vaccine Institute, creator of one of the vaccines administered in Cuba against COVID-19, the Soberana vaccine, said.

In the case of the HPV vaccine that will be administered in Cuba, it is the bivalent CECOLIN, which protects against serotypes 16 and 18, the most common, the scientist emphasized.

jdt/arm/mem/alb